SPDR Series Trust SPDR S&P Biotech ETF (XBI)
85.87
-0.40 (-0.46%)
NYSE · Last Trade: Jul 22nd, 1:36 AM EDT

The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.
Via MarketBeat · September 23, 2024

The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.
Via MarketBeat · July 13, 2023

Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility.
Via MarketBeat · March 22, 2023